Form D · Venture Capital Fund
Perceptive Xontogeny Venture Fund II, LP
New York, NY · CIK 0001851820
Offering snapshot reported May 12, 2021 · SEC filing
- Reported sold
- $515M Offering amount: $515M
- Investors reported
- 181 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2021 | Initial | $515,000,000 | No comparison | 181 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-399073
Total Amount Sold is inclusive of commitments by the General Partner and persons affiliated with the General Partner.
Source: Form D, filed May 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph E. Edelman | Executive |
| N/A Perceptive Xontogeny Venture Ii Gp, Llc | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
51 Astor Place 10 Th Floor
New York, NY, 10003
New York, NY, 10003